Competition

Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.



Sign up for a 7-day FREE trial today!



Latest News in Competition

  • August 27, 2026

    Binance.US Beats Sherman Claims, Rest Sent To Arbitration

    Cryptocurrency exchange Binance.US and a digital asset market data website have beaten for good antitrust claims in a proposed class action accusing them of working together to suppress a cryptocurrency's value by misstating its ranking, but Binance must face other claims in arbitration.

  • August 27, 2026

    Ugg-Maker Beats Rival Footwear Co.'s Antitrust Suit, For Now

    A California federal judge on Thursday tossed Quince's antitrust suit alleging Deckers uses sham trade dress litigation to block rivals, ruling Quince didn't sufficiently plead a sham litigation exception to the Noerr-Pennington doctrine, which immunizes businesses from antitrust liability for petitioning activity, but allowed Quince a chance to amend.

  • August 27, 2026

    Chamber Says FTC's Meta Appeal Trying To 'Rewrite' Law

    The U.S. Chamber of Commerce and other amicus filers urged the D.C. Circuit not to revive the Federal Trade Commission monopolization lawsuit targeting Meta's purchases of WhatsApp and Instagram, taking issue Thursday with how the FTC characterizes social media competition, consumer behavior and the law allowing it to sue.

  • August 27, 2026

    Full Play Owners To Pay $50M To Exit FIFA Bribery Dragnet

    The father and son owners of Argentine sports marketing agency Full Play Group SA have agreed to pay $50 million as part of a deferred prosecution deal that resolves criminal charges brought by Brooklyn federal prosecutors for paying tens of millions of dollars in bribes to Latin American soccer officials.

  • August 27, 2026

    5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight

    The U.S. Food and Drug Administration did not unlawfully remove blockbuster GLP-1 medications made by Eli Lilly & Co. and Novo Nordisk from the national drug shortage list, the Fifth Circuit ruled Thursday, handing a loss to compounding pharmacies that produce copycat doses of the drugs.

See more Competition news

Competition

Areas of Coverage

  • AGENCIES
  • U.S. Department of Justice, Antitrust Division
  • Federal Trade Commission, Bureau of Competition
  • European Commission, Competition Directorate
  • UK Competition and Markets Authority
  • Germany’s Federal Cartel Office
  • China’s Ministry Of Commerce
  • Japan Fair Trade Commission
  • Korea Fair Trade Commission
  • Canada’s Competition Bureau
  • Brazil’s Council for Economic Defense
  • POLICY & REGULATION
  • Clayton Act
  • Federal Trade Commission Act
  • Foreign Corrupt Practices Act
  • Racketeer Influenced and Corrupt Organizations Act
  • Robinson-Patman Act
  • Sherman Act
  • International antitrust legislation and regulation
  • ENFORCEMENT
  • Criminal charges over antitrust issues
  • Global cartel investigations and actions
  • Merger reviews and second requests
  • Merger challenges and divestiture orders
  • Anti-monopoly actions
  • Pharmaceutical pay-for-delay challenges
  • Bid-rigging probes
  • Kickback, bribery, and corruption cases
  • Challenges to state aid and other subsidies
  • LITIGATION
  • Antitrust class actions
  • Price-fixing cases
  • Illegal monopoly suits
  • PROFILES
  • Personnel moves
  • Profiles of competition practices

Readership

  • Antitrust and competition lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals